YP
GSK icon

Yellowstone Partners’s GSK GSK Stock Holding History

Yellowstone Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,900
Closed -$236K – 236
2015
Q3 		$236K Sell
4,900
-2,625
-35% -$137K 0.11% 158
2015
Q2 		$392K Sell
7,525
-679
-8% -$38.2K 0.18% 106
2015
Q1 		$473K Buy
8,204
+106
+1% +$6.08K 0.24% 83
2014
Q4 		$433K Buy
8,098
+1,459
+22% +$81.6K 0.23% 90
2014
Q3 		$382K Buy
6,639
+355
+6% +$21.8K 0.22% 94
2014
Q2 		$420K Buy
6,284
+421
+7% +$28.5K 0.25% 83
2014
Q1 		$392K Buy
+5,863
New +$396K 0.25% 88

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Yellowstone Partners's GSK Position: Q4 2015 in Review

Yellowstone Partners sold out of GSK (GSK) in Q4 2015, closing a stake of 4,900 shares — an estimated $236K sold.

Yellowstone Partners first reported a position in GSK in Q1 2014 and held it in 7 quarters. The position peaked at $473K in Q1 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Yellowstone Partners reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • Yellowstone Partners sold 4,900 GSK shares in Q4 2015, an estimated $236K.
  • Yellowstone Partners first reported a position in GSK in Q1 2014 and held it in 7 quarters.
  • Yellowstone Partners's GSK position peaked at $473K in Q1 2015.
  • 718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Yellowstone Partners's 13F filing for Q4 2015, filed 17 Aug 2016.